share_log

8-K: Dermata Therapeutics Provides Corporate Update and Reports Third Quarter 2024 Financial Results

SEC ·  Nov 15 00:27
Disclaimer: This content is for informational and educational purposes only and does not constitute a recommendation or endorsement of any specific investment or investment strategy. Read more